{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82657",
      "recalling_firm": "Akorn Inc",
      "address_1": "1925 W Field Ct Ste 300",
      "address_2": "N/A",
      "postal_code": "60045-4862",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S.A. Nationwide",
      "recall_number": "D-1241-2019",
      "product_description": "Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 25 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-25",
      "product_quantity": "5,380 cartons (25 ampules per carton)",
      "reason_for_recall": "Failed impurities/degradation specification: Out of Specification result for total impurity at 4.0% (Limit:  NMT 3.0%) at 12 months stability testing.",
      "recall_initiation_date": "20190423",
      "center_classification_date": "20190424",
      "termination_date": "20220728",
      "report_date": "20190501",
      "code_info": "Lot #: 011198, Exp 01/22"
    }
  ]
}